A Comprehensive Cohort (Pilot) Study in Type II Diabetes with High Risk of CAD in China (CCMR-301-CCDC)

Primary objectives:

1.      To assess whether inadequate glycemic control impact on the incidence of CV events in diabetic patients with high risk of CVD or prior/existing CVD;

2.      To assess the impact of certain combination of hypoglycemic therapies on the incidence of primary or secondary CV events;

3.      To assess the incidence of cardiovascular events in newly diagnosed vs. established diabetic patients with or without prior/existing CVD;

4.      To assess current hypoglycemic treatment patterns and outcomes in terms of HbA1c and glucose levels, and incidence/progression of diabetic complications other than CVD;

5. To assess safety profile of current therapy and reasons for change of hypoglycemic medications
6. To assess predictors and influencing factors for achieving target glycemic control and prevention of CVD
7. To assess the Impact of patients’ social economic profile on therapeutic outcomes
8. To assess physicians’ behavior toward prevention and managing cardiovascular disease in diabetic patients